Clinical Study of FB1001 in Patients

NCT06506305 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Optic Neuropathy
NAION - Non-Arteritic Ischemic Optic Neuropathy
APAC - Acute Primary Angle Closure
Glaucoma, Angle-Closure

Interventions

DRUG: FB1001

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]